Abstract
Immunogenic cell death (ICD) activates antitumor immunity by releasing damage-associated molecular patterns (DAMPs), which promote dendritic cell maturation and cytotoxic T lymphocyte infiltration. Sonodynamic therapy (SDT) offers deep tissue penetration for inducing ICD, but its efficacy is constrained by the hypoxic and glutathione (GSH)-rich tumor microenvironment. Herein, a biodegradable hyaluronic acid-based hydrogel (C-S-AH) was developed for cascaded H2S/Ca2+-amplified sonodynamic immunotherapy of osteosarcoma. The AH hydrogel co-encapsulates H2S/Ca2+-releasing C@MSHD nanoparticles and oxygen-vacancy-rich SnO2-x-FA sonosensitizers. Released H2S inhibits mitochondrial respiration by blocking cytochrome c oxidase, reducing oxygen consumption to relieve hypoxia while depleting GSH to amplify oxidative stress. Ca2+ overload further disrupts mitochondrial function and synergizes with SDT-generated ROS. This cascade induces robust ICD, promotes DC maturation and CD8+ T cell infiltration, and converts “cold” tumors into “hot” ones. In OS-bearing mouse models, this strategy significantly suppresses tumor growth and elicits long-term immune memory that effectively resists tumor rechallenge. This work provides a mechanistically validated strategy, supported by systematic controls and rescue experiments, for SDT-immunotherapy in immunotherapy-resistant solid tumors.

京公网安备11010802044758号
Comments on this article